Alzheimer's disease

Perspectives in Biology and Medicine

Volumn 40, Issue 2, 1997, Pages 230-245

  Gilman, Sid ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASCORBIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; ESTROGEN; GALANTAMINE; INDOMETACIN; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NICOTINE; NICOTINIC AGENT; SELEGILINE;

ALZHEIMER DISEASE; CHROMOSOME 1; CHROMOSOME 21; CLINICAL EXAMINATION; CLINICAL TRIAL; HUMAN; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENILE PLAQUE;

EID: 0030702916     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: 10.1353/pbm.1997.0020     Document Type: Review

References (54)

1. ALZHEIMER, A. Über eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiatr. 64:146-148, 1907.
2. English translation, WILKIN, R. H., and BRODY, I. A. Arch. Neurol. 21:109-110, 1969.
3. AMADUCCI, L. A.; ROCCA, W. A.; and SCHOENBERG, B. S. Origin of the distinction between Alzheimer's disease and senile dementia: How history can clarify nosology. Neurology 36:1497-1499, 1986.
4. COUNCIL ON SCIENTIFIC AFFAIRS. Dementia. JAMA 256:2234-2238, 1986.
5. PATTERSON, M. B.; SCHNELL, A.; MARTIN, R. J.; et al. Assessment of psychiatric symptoms in Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 3:21-30, 1990.
6. MCKHANN, G.; DRACHMAN, D.; FOLSTEIN, M.; et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944, 1984.
7. TIERNEY, M. C.; FISHER, R. H.; LEWIS, A. J.; et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: A clinicopathologic study of 57 cases. Neurology 38:359-364, 1988.
8. EVANS, D. A.; FUNKENSTEIN, H. H.; ALBERT, M. S.; et al. Prevalence of Alzheimer's disease in a community population of older persons: Higher than previously reported. JAMA 262:2551-2556, 1989.
9. BENNETT, D. A., and EVANS, D. A. Alzheimer's disease. Dis. Mon. 38:1-64, 1992.
10. BECKETT, L. A., and EVANS, D. A. Estimating prevalence and incidence of chronic conditions in the elderly: Design and sampling issues. Alzheimer Dis. Assoc. Disord. 8:S274-280, 1994.
11. RICE, D.; FOX, P. J.; MAX, W.; et al. The economic burden of Alzheimer's disease. Health Aff. (Millwood) 12:164-176, 1993.
12. GLENNARD, G. S., and WONG, C. W. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:885-890, 1984.
13. SELKOE, D. J. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Ann. Rev. Cell Biol. 10:373-403, 1994.
14. HOFMAN, A.; SCHULTE, W.; TANJA, T. A.; et al. History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease. Neurology 39:1589-1592, 1989.
15. GOATE, A.; CHARTIER-HARLIN, M.-C.; MULLAN, M.; et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706, 1991.
16. MORRELL, J.; FARLOW, M.; GHETTI, B.; et al. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254:97-99, 1991.
17. CHARTIER, H. M.; CRAWFORD, F.; HOULDEN, H.; et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353:844-846, 1991.
18. WISNIEWSKI, K. E.; DALTON, A. J.; MCLACHLAN, C.; et al. Alzheimer's disease in Down's syndrome: Clinicopathological studies. Neurology 35:957-961, 1985.
19. SCHELLENBERG, G. D.; BIRD, T. D.; WIJSMAN, E. M.; et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258:668-671, 1992.
20. ST. GEORGE-HYSLOP, P.; HAINES, J.; ROGAEV, E.; et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nature Genet. 2:330-334, 1992.
21. LEVY-LAHAD, E.; WASCO, W.; POORKAJ, P.; et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977, 1995.
22. SHERRINGTON, R.; ROGAEV, E. L.; LIANG, Y.; et al. Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease. Nature 375: 754-760, 1995.
23. ROGAEV, E. I.; SHERRINGTON, R.; ROGAEVA, E. R.; et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type gene. Nature 376:775-778, 1995.
24. BIRD, T. D.; LAMPE, T. H.; NEMENS, G. W.; et al. Familial Alzheimer's disease in American descendants of the Volga Germans: Probable genetic founder effect. Ann. Neurol. 23:25-31, 1988.
25. LEVITAN, D., and GREENWALD, I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377: 351-354, 1995.
26. STRITTMATTER, W. J.; SAUNDERS, A. M.; SCHMECHEL, D. E.; et al. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:1977-1981, 1993.
27. CORDER, E. H.; SAUNDERS, A. M.; STRITTMATTER, W. J.; et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923, 1993.
28. STRITTMATTER, W. J.; WEISGRABER, K. H.; HUAND, D.; et al. Binding of human apolipoprotein E to synthetic amyloid β-peptide: Isoform specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:8098-8102, 1993.
29. SCHMECHEL, D. E.; SAUNDERS, A. M.; STRITTMATTER, W. J.; et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:9649-9653, 1993.
30. REBECK, G. W.; REITER, J. S.; STRICKLAND, D. K.; et al. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11:575-580, 1993.
31. SAUNDERS, A. M.; STRITTMATTER, W. J.; SCHMECHEL, D.; et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472, 1993.
32. HOULDEN, H.; CROOK, R.; DUFF, K.; et al. Confirmation that the apolipoprotein E4 allele is associated with late onset, familial Alzheimer's disease. Neurodegener. 2:283-286, 1993.
33. KUSSISTO, J.; KOIVISTO, K.; KERVINEN, K.; et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: Population based study. Brit. Med. J. 309:636-638, 1994.
34. ROSES, A. D. On the metabolism of apolipoprotein E and the Alzheimer diseases. Exp. Neurol. 132:149-156, 1995.
35. ROSES, A. D.; STRITTMATTER, W. J.; SAUNDERS, A. M.; et al. Apolipoprotein E and Alzheimer's disease: State of the field after two years. In Apolipoprotein E and Alzheimer's Disease, edited by A. D. ROSES, K. WEISGRABER, and Y. CHIRISTEN. Berlin: Springer-Verlag, 1996.
36. POLVIKOSKI, T.; SULKAVA, R.; HALTIA, M.; et al. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. New Engl. J. Med. 333:1242-1247, 1995.
37. SOININEN, H. S., and RIEKKINEN, P. J. Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci. 19:224-228, 1996.
38. KOUNNAS, M. Z.; MOIR, R. D.; REBECK, G. W.; et al. LDL receptor-related protein, a multifunctional Apo-E receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 82:331-340, 1995.
39. REIMAN, E. M.; CASELLI, R. J.; YUN, L. S.; et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the E4 allele for apolipoprotein E. New Engl. J. Med. 334:752-758, 1996.
40. HENSLEY, K.; CARNEY, J. M.; MATTSON, M. P.; et al. A model for beta amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. USA 91:3270-3264, 1994.
41. HARDY, J. A., and HIGGIN, G. A. Alzheimer's disease: The amyloid cascade hypothesis. Science 256:184-185, 1992.
42. ETCHEBERRIGARY, R.; ITO, E.; KIM, C. S.; et al. Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels. Science 264:276-279, 1984.
43. GALDZICKI, A.; FUKUYAMA, R.; WADHWANI, K. C.; et al. Beta amyloid increases choline conductance of PC12 cells: Possible mechanism of toxicity in Alzheimer's disease. Brain Res. 646:332-336, 1994.
44. LOO, D. T.; COPARCI, A.; PIKE, C. J.; et al. Apoptosis is induced by beta amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA 90:7951-7955, 1993.
45. ZHANG, M.; KATZMAN, R.; SALMON, D.; et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education. Ann. Neurol. 27:428-437, 1990.
46. SNOWDON, D. A.; KEMPER, S. J.; MORTIMER, J. A.; et al. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. JAMA 275:528-532, 1996.
47. CRAPPER, D. R.; KRISHMANN, S. S.; and DALTON, A. J. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 180:511-513, 1973.
48. CRAPPER, D. R.; KRISHMANN, S. S.; and DALTON, A. J. Aluminum, neurofibrillary degeneration and Alzheimer's disease. Brain 99:67-80, 1976.
49. MARKESBERY, W. R.; EHMANN, W. D.; HOSSAIN, T. I. M.; et al. Instrumental neutron activation analysis of brain aluminum in Alzheimer's disease and aging. Ann. Neurol. 10:511-516, 1981.
50. WILCOCK, G. K., and HARROLD, P. L. Treatment of Alzheimer's disease: Future directions. Acta Neurol. Scand. S165:128-136, 1996.
51. LEE, P. N. Smoking and Alzheimer's disease: A review of the epidemiological evidence. Neuroepidemiology 13:131-144, 1994.
52. RICH, J. B.; RASMUSSON, D. X.; FOLSTEIN, M. F.; et al. Nonsteroidal antiinflammatory drugs in Alzheimer's disease. Neurology 45:51-55, 1995.
53. ROGERS, J.; KIRBY, L. C.; HEMPELMAN, S. R.; et al. Clinical trial of indomethacin in AD. Neurology 43:1609-1611, 1993.
54. GAMES, D.; ADAMS, D.; ALESSANDRINI, R.; et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527, 1995.